1 year return (CAGR)
-77.53%
Virax Biolabs Group Limited Ordinary Shares Exchange (NASDAQ, USD)
VRAX
2.40
+0.04 (+20.97%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-62.18%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.61M
Price/Sales
202.25
Ent value
-1.10M
Price/Book
0.32
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 0.18 |
| Daily high | 0.22 |
| Daily low | 0.17 |
| Daily Volume | 3.15M |
| All-time high | 208.00 |
| 1y analyst estimate | 25.00 |
| Beta | 1.34 |
| EPS (TTM) | -13.77 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| VRAX | S&P500 | |
| Current price drop from All-time high | -98.85% | -0.84% |
| Highest price drop | -99.95% | -56.47% |
| Date of highest drop | 10 Apr 2026 | 9 Mar 2009 |
| Avg drop from high | -96.89% | -10.68% |
| Avg time to new high | 162 days | 12 days |
| Max time to new high | 965 days | 1805 days |
News
